Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heartbeam, Inc. - Common Stock (NQ:BEAT)

1.120 -0.030 (-2.61%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 378,323
Open 1.120
Bid (Size) 1.130 (5,600)
Ask (Size) 1.140 (100)
Prev. Close 1.150
Today's Range 1.090 - 1.150
52wk Range 0.5400 - 4.000
Shares Outstanding 34,260,799
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Heartbeam Inc. (NASDAQ: BEAT) Partners with Mount Sinai to Accelerate AI-ECG Development and Validation
Via Investor Brand Network
Topics Artificial Intelligence
HeartBeam Inc. (NASDAQ: BEAT) Featured in Coverage of the 38th Annual ROTH Conference
Via Investor Brand Network
Topics Intellectual Property

Performance

YTD
-53.9%
-53.9%
1 Month
-20.0%
-20.0%
3 Month
-61.8%
-61.8%
6 Month
-31.7%
-31.7%
1 Year
-43.4%
-43.4%

More News

Read More
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam (BEAT) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Artificial Intelligence Earnings
HeartBeam Inc (NASDAQ:BEAT) Reports Q4 2025 Earnings, Highlights FDA Clearance and Commercial Launch ↗
Via Chartmill
News headline image
HeartBeam Reports Fourth Quarter and Full Year 2025 Results
From HeartBeam, Inc.
Via Business Wire
News headline image
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study ↗
Via Stocktwits
News headline image
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market ↗
Via Stocktwits
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Moves Forward Focused on Advancing Portable, High-Fidelity Cardiac Monitoring
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Schedules March 12 Conference Call to Review Q4 and Full-Year 2025 Results
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study
From HeartBeam, Inc.
Via Business Wire
News headline image
HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Commercial Partnership With ClearCardio as First Customer and Strategic Investor
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Upgraded to Buy as New Joseph Gunnar Report Raises Price Target on Commercialization Momentum
Via Investor Brand Network
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Showcased for Advancing Innovative ECG Platform
Via Investor Brand Network
Topics Intellectual Property
HeartBeam Inc. (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer
Via Investor Brand Network
News headline image
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer
From HeartBeam, Inc.
Via Business Wire

Frequently Asked Questions

Is Heartbeam, Inc. - Common Stock publicly traded?
Yes, Heartbeam, Inc. - Common Stock is publicly traded.
What exchange does Heartbeam, Inc. - Common Stock trade on?
Heartbeam, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Heartbeam, Inc. - Common Stock?
The ticker symbol for Heartbeam, Inc. - Common Stock is BEAT on the Nasdaq Stock Market
What is the current price of Heartbeam, Inc. - Common Stock?
The current price of Heartbeam, Inc. - Common Stock is 1.120
When was Heartbeam, Inc. - Common Stock last traded?
The last trade of Heartbeam, Inc. - Common Stock was at 03/24/26 04:00 PM ET
What is the market capitalization of Heartbeam, Inc. - Common Stock?
The market capitalization of Heartbeam, Inc. - Common Stock is 38.37M
How many shares of Heartbeam, Inc. - Common Stock are outstanding?
Heartbeam, Inc. - Common Stock has 38M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.